• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2001 Fiscal Year Final Research Report Summary

Study on transcutaneous immunization using peptides of melanomd entigens with high affinity to MHC

Research Project

Project/Area Number 11470181
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Dermatology
Research InstitutionShinshu University School of Medicine

Principal Investigator

SAIDA Toshiaki  Shinshu Univ. School of Med, Prof., 医学部, 教授 (10010381)

Co-Investigator(Kenkyū-buntansha) KAWAKAMI Yutaka  Keio Univ., School of Med., Prof., 医学部, 教授 (50161287)
YAMAZAKI Yoriko  Shinshu Univ., School of Med, Assistant, 医学部, 助手 (80242684)
KAWACHI Shigeo  Shinshu Univ., School of Med, Assistant Prof., 医学部, 講師 (20143969)
Project Period (FY) 1999 – 2001
KeywordsMalignant melnomd / Immunotherapy / Antigen peptide / Transcutaneous immunization
Research Abstract

In our previous studey, we investigated induction of cytotoxic T lymphocytes ( CTL ) against melanoma cells by means of percutaneous application of epitope peptide of melanoma antigens. Application of mouse-gp100 peptide ( EGSRNQDWL ) but not human gp100 peptide ( KVPPNQDWL ) on tape-stripped skin of ear and abdomen of C57BL/6 mice induced slight immune response against B16 mouse melanoma, which was confirmed by CTL assay.
This year, we investigated whether this treatment could induce delayed type hypersensitivity reaction ( DTH ) and inhibit growth of B16 melanoma in vivo. Application of the mouse-gp100 peptide on the tapestripped skin of the ear and abdomen of the mice induced DTH reaction, which was detected by foodpad test. However, growth of B16 melanoma was not significantly inhibited in the mice treated with the application of mouse-gp100 peptide.
Seo et al reported strong inhibitory effect on the growth of B16 melanoma with almost the same treatment in this murine melanoma system. However, we could not confirm the excellent results in our study. Further study may be necessary to determine the effect of this unique method of immunization.

  • Research Products

    (15 results)

All Other

All Publications (15 results)

  • [Publications] Kageshita, T., et al.: "Growth inhibition of human malignant melanoma transefcted with human IFN-β gene by means of cationic liposomes"Melanoma Res.. 11. 337-342 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Saida, T.: "Recent advances in melanoma research"J Dermatol Sci.. 24. 1-13 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kageshita, T., et al.: "Los of β-catenin expression associated with disease progression in malignant melanoma"Br J Dermatol. 145. 210-216 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 斎田俊明: "悪性黒色腫に対する抗がん剤の適正使用ガイドライン(試案)"Skin Cancer. 16. 158-169 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kiniwa, Y., et al.: "Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma"Cancer Res.. 61. 7900-7907 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Wakamatsu, K., et al.: "Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression ; 10years' experience"Melanoma Res.. 12(in press). (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 斎田俊明, 他: "悪性黒色腫の診断・治療指針"金原出版. 196 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kageshita,T., Saida,T. et al: "Growth inhibition of human malignant melanoma transfected with the human IFN-β gene by means of catiuonic liposomes"Melanoma Res. 11. 337-342 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Saida,T.: "Recent advances in melanoma research"J Dermartol Sci. 24. 1-13 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kageshita,T., Saida,T. et al: "Loss of β catenin expression associated with disease progression in malignant melanoma"Br J Dermatol. 145. 210-216 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Saida,T. et al: "Proposition of guidelines for chemotherapy od malignant melanoma based on the data obtained from relevant literatures ( in Japanese )"Skin Cancer. 16. 158-169 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kiniwa,Y., Saida,T. et al: "Tumor antigens isolated from a patient with vitiligo and T-cell infiltrated melanoma"Cancer Res. 61. 7900-7907 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Wakamatsu,K., Kageshita,T., Furue,M., Hatta,Y., Kiyohara,Y., Nakayama,J., Ono,T., Saida,T., Takata,T., Tsuchida,T., Uhara,H., Yamamoto,A., Yamazaki,N., Naito,A., Ito,S.: "Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression: 10 years' experience"Melanoma Res. 12 ( in press ). (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ueyama,Y., Saida,T., Inokuchi,S., (eds): "Human Skin and Hair in immunodificient Mice : Experimental studies and clinical applications"Central Institute for Experimental Animals, Kawasaki. (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Saida,T., Yamamoto,A., (eds): "Diagnosia and Treatment of Malignant Melanoma"Kanehara, Tokyo. (2001)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2003-09-17  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi